{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:27:12Z","timestamp":1794090432331,"version":"4.8.0"},"reference-count":329,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"DOI":"10.1038\/s41596-026-01453-8","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:54:10Z","timestamp":1791298450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["T cell immunomonitoring: a comparative analysis of traditional and novel methods to quantify and characterize human antigen-specific T cells"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9573-903X","authenticated-orcid":false,"given":"Sandra","family":"Lazzaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5968-2542","authenticated-orcid":false,"given":"Geert","family":"Leroux-Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9758-2186","authenticated-orcid":false,"given":"Sylvia","family":"Janetzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8927-8660","authenticated-orcid":false,"given":"Bruno","family":"Salaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-2045","authenticated-orcid":false,"given":"Laura","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1673-9758","authenticated-orcid":false,"given":"Katka","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-5566","authenticated-orcid":false,"given":"Isabel","family":"Poschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4490-7574","authenticated-orcid":false,"given":"Lukas","family":"Bunse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-8266","authenticated-orcid":false,"given":"Marij J. P.","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0384-8408","authenticated-orcid":false,"given":"Michael","family":"Fehlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-6459","authenticated-orcid":false,"given":"Sofie","family":"Pattyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3712-2979","authenticated-orcid":false,"given":"Gwenn","family":"Waerlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2446-382X","authenticated-orcid":false,"given":"Liselotte","family":"Brix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-7341","authenticated-orcid":false,"given":"Noah J.","family":"Tubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1196-1715","authenticated-orcid":false,"given":"Jeffrey J.","family":"Molldrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9770-8723","authenticated-orcid":false,"given":"Viola","family":"Denninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7077-4349","authenticated-orcid":false,"given":"Wim J. E.","family":"van Esch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-7153","authenticated-orcid":false,"given":"Nikolaj Pagh","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-9887","authenticated-orcid":false,"given":"Yolanda D.","family":"Mahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-5449","authenticated-orcid":false,"given":"Florian","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-9472","authenticated-orcid":false,"given":"Kilian","family":"Schober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-0448","authenticated-orcid":false,"given":"Sven D.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1453_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41577-023-00911-8","volume":"24","author":"KM Ashby","year":"2024","unstructured":"Ashby, K. M. & Hogquist, K. A. A guide to thymic selection of T cells. Nat. Rev. Immunol. 24, 103\u2013117 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1453_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nri1292","volume":"4","author":"J Nikolich-Zugich","year":"2004","unstructured":"Nikolich-Zugich, J., Slifka, M. K. & Messaoudi, I. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4, 123\u2013132 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"1453_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651\u2013668 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1453_CR4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/2159-8290.CD-18-1357","volume":"9","author":"PA Ott","year":"2019","unstructured":"Ott, P. A. & Wu, C. J. Cancer vaccines: steering T cells down the right path to eradicate tumors. Cancer Discov. 9, 476\u2013481 (2019).","journal-title":"Cancer Discov."},{"key":"1453_CR5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/vaccines12050478","volume":"12","author":"Z Zhuang","year":"2024","unstructured":"Zhuang, Z. et al. Harnessing T-cells for enhanced vaccine development against viral infections.Vaccines 12, 478 (2024).","journal-title":"Vaccines"},{"key":"1453_CR6","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma, P. et al. Immune checkpoint therapy-current perspectives and future directions. Cell 186, 1652\u20131669 (2023).","journal-title":"Cell"},{"key":"1453_CR7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.132.3.401","volume":"132","author":"RJ Mangi","year":"1970","unstructured":"Mangi, R. J. & Mardiney, M. R. Jr. The in vitro transformation of frozen-stored lymphocytes in the mixed lymphocyte reaction and in culture with phytohemagglutinin and specific antigens. J. Exp. Med. 132, 401\u2013416 (1970).","journal-title":"J. Exp. Med."},{"key":"1453_CR8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0264-410X(94)90290-9","volume":"12","author":"G Leroux-Roels","year":"1994","unstructured":"Leroux-Roels, G. et al. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines. Vaccine 12, 812\u2013818 (1994).","journal-title":"Vaccine"},{"key":"1453_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2172-8-21","volume":"8","author":"V Goodell","year":"2007","unstructured":"Goodell, V., dela Rosa, C., Slota, M., MacLeod, B. & Disis, M. L. Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses. BMC Immunol. 8, 21 (2007).","journal-title":"BMC Immunol."},{"key":"1453_CR10","doi-asserted-by":"crossref","first-page":"112907","DOI":"10.1016\/j.jim.2020.112907","volume":"487","author":"D Di Blasi","year":"2020","unstructured":"Di Blasi, D., Claessen, I., Turksma, A. W., van Beek, J. & Ten Brinke, A. Guidelines for analysis of low-frequency antigen-specific T cell results: dye-based proliferation assay vs 3H-thymidine incorporation. J. Immunol. Methods 487, 112907 (2020).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1046\/j.1440-1711.1999.00877.x","volume":"77","author":"CR Parish","year":"1999","unstructured":"Parish, C. R. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol. Cell Biol. 77, 499\u2013508 (1999).","journal-title":"Immunol. Cell Biol."},{"key":"1453_CR12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0022-1759(91)90377-R","volume":"140","author":"PL Huong","year":"1991","unstructured":"Huong, P. L. et al. Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. An easy and low cost alternative to radioactive thymidine incorporation. J. Immunol. Methods 140, 243\u2013248 (1991).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-1759(12)80012-3","volume":"147","author":"P Carayon","year":"1992","unstructured":"Carayon, P. & Bord, A. Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J. Immunol. Methods 147, 225\u2013230 (1992).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR14","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/nprot.2007.296","volume":"2","author":"BJ Quah","year":"2007","unstructured":"Quah, B. J., Warren, H. S. & Parish, C. R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2, 2049\u20132056 (2007).","journal-title":"Nat. Protoc."},{"key":"1453_CR15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0022-1759(90)90322-M","volume":"133","author":"SA Weston","year":"1990","unstructured":"Weston, S. A. & Parish, C. R. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133, 87\u201397 (1990).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2012.02.012","volume":"379","author":"BJ Quah","year":"2012","unstructured":"Quah, B. J. & Parish, C. R. New and improved methods for measuring lymphocyte proliferation in vitro and in vivo using CFSE-like fluorescent dyes. J. Immunol. Methods 379, 1\u201314 (2012).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11538-010-9524-5","volume":"73","author":"HT Banks","year":"2011","unstructured":"Banks, H. T. et al. Estimation of cell proliferation dynamics using CFSE data. Bull. Math. Biol. 73, 116\u2013150 (2011).","journal-title":"Bull. Math. Biol."},{"key":"1453_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00285-006-0046-6","volume":"54","author":"T Luzyanina","year":"2007","unstructured":"Luzyanina, T. et al. Computational analysis of CFSE proliferation assay. J. Math. Biol. 54, 57\u201389 (2007).","journal-title":"J. Math. Biol."},{"key":"1453_CR19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/cyto.a.24830","volume":"105","author":"JE Davis","year":"2024","unstructured":"Davis, J. E., Ludford-Menting, M., Koldej, R. & Ritchie, D. S. Modified cell trace violet proliferation assay preserves lymphocyte viability and allows spectral flow cytometry analysis. Cytometry A 105, 394\u2013403 (2024).","journal-title":"Cytometry A"},{"key":"1453_CR20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/ACI.0b013e3283511396","volume":"12","author":"SE Hines","year":"2012","unstructured":"Hines, S. E., Pacheco, K. & Maier, L. A. The role of lymphocyte proliferation tests in assessing occupational sensitization and disease. Curr. Opin. Allergy Clin. Immunol. 12, 102\u2013110 (2012).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"1453_CR21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/vaccines12091049","volume":"12","author":"D Pasupuleti","year":"2024","unstructured":"Pasupuleti, D. et al. Evaluating nanoparticulate vaccine formulations for effective antigen presentation and T-cell proliferation using an in vitro overlay assay. Vaccines 12, 1049 (2024).","journal-title":"Vaccines"},{"key":"1453_CR22","doi-asserted-by":"crossref","first-page":"1021500","DOI":"10.3389\/fimmu.2022.1021500","volume":"13","author":"I Leroux-Roels","year":"2022","unstructured":"Leroux-Roels, I. et al. A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine. Front. Immunol. 13, 1021500 (2022).","journal-title":"Front. Immunol."},{"key":"1453_CR23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/s41596-020-00467-0","volume":"16","author":"S Kiesgen","year":"2021","unstructured":"Kiesgen, S., Messinger, J. C., Chintala, N. K., Tano, Z. & Adusumilli, P. S. Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity. Nat. Protoc. 16, 1331\u20131342 (2021).","journal-title":"Nat. Protoc."},{"key":"1453_CR24","first-page":"181","volume":"14","author":"KT Brunner","year":"1968","unstructured":"Brunner, K. T., Mauel, J., Cerottini, J. C. & Chapuis, B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14, 181\u2013196 (1968).","journal-title":"Immunology"},{"key":"1453_CR25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0022-1759(74)90073-8","volume":"4","author":"RM Thorn","year":"1974","unstructured":"Thorn, R. M., Palmer, J. C. & Manson, L. A. A simplified 51Cr-release assay for killer cells. J. Immunol. Methods 4, 301\u2013315 (1974).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","volume":"115","author":"T Decker","year":"1988","unstructured":"Decker, T. & Lohmann-Matthes, M. L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 115, 61\u201369 (1988).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jim.2006.01.011","volume":"311","author":"E Dev\u00eavre","year":"2006","unstructured":"Dev\u00eavre, E., Romero, P. & Mahnke, Y. D. LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8+ T-cells by flow cytometry. J. Immunol. Methods 311, 31\u201346 (2006).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR28","doi-asserted-by":"crossref","first-page":"867189","DOI":"10.3389\/fimmu.2022.867189","volume":"13","author":"M Cenerenti","year":"2022","unstructured":"Cenerenti, M., Saillard, M., Romero, P. & Jandus, C. The era of cytotoxic CD4 T cells. Front. Immunol. 13, 867189 (2022).","journal-title":"Front. Immunol."},{"key":"1453_CR29","doi-asserted-by":"crossref","first-page":"103387","DOI":"10.1016\/j.isci.2021.103387","volume":"24","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. The role of protease-activated receptor 1 signaling in CD8 T cell effector functions. iScience 24, 103387 (2021).","journal-title":"iScience"},{"key":"1453_CR30","doi-asserted-by":"crossref","first-page":"e89357","DOI":"10.1371\/journal.pone.0089357","volume":"9","author":"MA Karimi","year":"2014","unstructured":"Karimi, M. A. et al. Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay. PLoS ONE 9, e89357 (2014).","journal-title":"PLoS ONE"},{"key":"1453_CR31","unstructured":"CreativeBiolabs. Incucyte\u00ae SX5 Live-Cell Imaging Platform https:\/\/neuros.creative-biolabs.com\/incucyte-sx5-live-cell-imaging-platform.htm?msclkid=f9772420e26f1fc36e3a4d10f5c8d032&utm (2025)."},{"key":"1453_CR32","unstructured":"Agilent. xCELLigence Real-Time Cell Analysis https:\/\/www.agilent.com\/en\/product\/cell-analysis\/real-time-cell-analysis (2025)."},{"key":"1453_CR33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood-2009-10-250993","volume":"116","author":"PG Maslak","year":"2010","unstructured":"Maslak, P. G. et al. Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia. Blood 116, 171\u2013179 (2010).","journal-title":"Blood"},{"key":"1453_CR34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0022-1759(95)00235-9","volume":"190","author":"JE McElhaney","year":"1996","unstructured":"McElhaney, J. E., Pinkoski, M. J., Upshaw, C. M. & Bleackley, R. C. The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity. J. Immunol. Methods 190, 11\u201320 (1996).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","volume":"309","author":"AJ McMichael","year":"1983","unstructured":"McMichael, A. J., Gotch, F. M., Noble, G. R. & Beare, P. A. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309, 13\u201317 (1983).","journal-title":"N. Engl. J. Med."},{"key":"1453_CR36","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41591-022-01937-6","volume":"28","author":"CD Palmer","year":"2022","unstructured":"Palmer, C. D. et al. Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results. Nat. Med. 28, 1619\u20131629 (2022).","journal-title":"Nat. Med."},{"key":"1453_CR37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-1759(83)90308-3","volume":"65","author":"CC Czerkinsky","year":"1983","unstructured":"Czerkinsky, C. C., Nilsson, L. A., Nygren, H., Ouchterlony, O. & Tarkowski, A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65, 109\u2013121 (1983).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586, 594\u2013599 (2020).","journal-title":"Nature"},{"key":"1453_CR39","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","volume":"398","author":"APS Munro","year":"2021","unstructured":"Munro, A. P. S. et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet 398, 2258\u20132276 (2021).","journal-title":"Lancet"},{"key":"1453_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas, L. A. et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 618, 144\u2013150 (2023).","journal-title":"Nature"},{"key":"1453_CR41","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41591-024-02851-9","volume":"30","author":"AR Rappaport","year":"2024","unstructured":"Rappaport, A. R. et al. A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nat. Med. 30, 1013\u20131022 (2024).","journal-title":"Nat. Med."},{"key":"1453_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10096-005-1377-8","volume":"24","author":"T Meier","year":"2005","unstructured":"Meier, T., Eulenbruch, H. P., Wrighton-Smith, P., Enders, G. & Regnath, T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 24, 529\u2013536 (2005).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"1453_CR43","doi-asserted-by":"crossref","unstructured":"Janetzki, S. Elispot for Rookies (and Experts Too) (Springer, 2016).","DOI":"10.1007\/978-3-319-45295-1"},{"key":"1453_CR44","doi-asserted-by":"crossref","first-page":"113452","DOI":"10.1016\/j.jim.2023.113452","volume":"515","author":"M Berrong","year":"2023","unstructured":"Berrong, M. et al. Validation of the performance and suitability of a new class of FBS optimized for use in single-cell functional assays. J. Immunol. Methods 515, 113452 (2023).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00262-009-0788-2","volume":"59","author":"S Janetzki","year":"2010","unstructured":"Janetzki, S. et al. Performance of serum-supplemented and serum-free media in IFN\u03b3 Elispot Assays for human T cells. Cancer Immunol. Immunother. 59, 609\u2013618 (2010).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR46","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-0716-3690-9_17","volume":"2768","author":"N Ahlborg","year":"2024","unstructured":"Ahlborg, N., Smedman, C. & Makower, B. Triple-color FluoroSpot analysis of polyfunctional antigen-specific T cells by quantification of spot-forming units and relative spot volumes. Methods Mol. Biol. 2768, 297\u2013304 (2024).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-3690-9_1","volume":"2768","author":"S Janetzki","year":"2024","unstructured":"Janetzki, S. Important considerations for ELISpot validation. Methods Mol. Biol. 2768, 1\u201313 (2024).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00262-007-0380-6","volume":"57","author":"S Janetzki","year":"2008","unstructured":"Janetzki, S. et al. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC\/SVI). Cancer Immunol. Immunother. 57, 303\u2013315 (2008).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR49","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/nprot.2015.068","volume":"10","author":"S Janetzki","year":"2015","unstructured":"Janetzki, S. et al. Guidelines for the automated evaluation of Elispot assays. Nat. Protoc. 10, 1098\u20131115 (2015).","journal-title":"Nat. Protoc."},{"key":"1453_CR50","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cells3041102","volume":"3","author":"S Janetzki","year":"2014","unstructured":"Janetzki, S., Rueger, M. & Dillenbeck, T. Stepping up ELISpot: multi-level analysis in FluoroSpot assays. Cells 3, 1102\u20131115 (2014).","journal-title":"Cells"},{"key":"1453_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder, R. A., Darrah, P. A. & Roederer, M. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8, 247\u2013258 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1453_CR52","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01310-22","volume":"96","author":"A Nilsson","year":"2022","unstructured":"Nilsson, A. et al. Four-parameter FluoroSpot assay reveals that the varicella zoster virus elicits a robust memory T cell IL-10 response throughout childhood. J. Virol. 96, e0131022 (2022).","journal-title":"J. Virol."},{"key":"1453_CR53","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00262-010-0875-4","volume":"59","author":"Z Moodie","year":"2010","unstructured":"Moodie, Z. et al. Response definition criteria for ELISPOT assays revisited. Cancer Immunol. Immunother. 59, 1489\u20131501 (2010).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-61779-325-7_15","volume":"792","author":"Z Moodie","year":"2012","unstructured":"Moodie, Z., Price, L., Janetzki, S. & Britten, C. M. Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories. Methods Mol. Biol. 792, 185\u2013196 (2012).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/2326-6066.CIR-15-0105","volume":"4","author":"S Gross","year":"2016","unstructured":"Gross, S. et al. Short peptide vaccine induces CD4+ T helper cells in patients with different solid cancers. Cancer Immunol. Res. 4, 18\u201325 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"1453_CR56","doi-asserted-by":"crossref","first-page":"e10533","DOI":"10.1371\/journal.pone.0010533","volume":"5","author":"M Wang","year":"2010","unstructured":"Wang, M. et al. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses. PLoS ONE 5, e10533 (2010).","journal-title":"PLoS ONE"},{"key":"1453_CR57","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/bloodadvances.2022009274","volume":"7","author":"M Noviello","year":"2023","unstructured":"Noviello, M. et al. Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients. Blood Adv. 7, 5446\u20135457 (2023).","journal-title":"Blood Adv."},{"key":"1453_CR58","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1453_CR59","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507\u20131517 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1453_CR60","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1453_CR61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","volume":"547","author":"PA Ott","year":"2017","unstructured":"Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"1453_CR62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.1991.tb00578.x","volume":"119","author":"B Sander","year":"1991","unstructured":"Sander, B., Andersson, J. & Andersson, U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119, 65\u201393 (1991).","journal-title":"Immunol. Rev."},{"key":"1453_CR63","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood.V86.4.1408.bloodjournal8641408","volume":"86","author":"LJ Picker","year":"1995","unstructured":"Picker, L. J. et al. Direct demonstration of cytokine synthesis heterogeneity among human memory\/effector T cells by flow cytometry. Blood 86, 1408\u20131419 (1995).","journal-title":"Blood"},{"key":"1453_CR64","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/nprot.2006.268","volume":"1","author":"L Lamoreaux","year":"2006","unstructured":"Lamoreaux, L., Roederer, M. & Koup, R. Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 1, 1507\u20131516 (2006).","journal-title":"Nat. Protoc."},{"key":"1453_CR65","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/eji.202170126","volume":"51","author":"A Cossarizza","year":"2021","unstructured":"Cossarizza, A. et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur. J. Immunol. 51, 2708\u20133145 (2021).","journal-title":"Eur. J. Immunol."},{"key":"1453_CR66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","volume":"323","author":"H Horton","year":"2007","unstructured":"Horton, H. et al. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J. Immunol. Methods 323, 39\u201354 (2007).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR67","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/nm1292","volume":"11","author":"M Frentsch","year":"2005","unstructured":"Frentsch, M. et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 11, 1118\u20131124 (2005).","journal-title":"Nat. Med."},{"key":"1453_CR68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","volume":"110","author":"M Wolfl","year":"2007","unstructured":"Wolfl, M. et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 110, 201\u2013210 (2007).","journal-title":"Blood"},{"key":"1453_CR69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/ijms22010073","volume":"22","author":"DSM Chatzileontiadou","year":"2020","unstructured":"Chatzileontiadou, D. S. M., Sloane, H., Nguyen, A. T., Gras, S. & Grant, E. J. The many faces of CD4+ T cells: immunological and structural characteristics. Int. J. Mol. Sci. 22, 73 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1453_CR70","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/infdis\/jiac327","volume":"227","author":"I Leroux-Roels","year":"2023","unstructured":"Leroux-Roels, I. et al. Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase 1\/2 randomized clinical trial. J. Infect. Dis. 227, 761\u2013772 (2023).","journal-title":"J. Infect. Dis."},{"key":"1453_CR71","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nbt.3187","volume":"33","author":"L Lin","year":"2015","unstructured":"Lin, L. et al. COMPASS identifies T-cell subsets correlated with clinical outcomes. Nat. Biotechnol. 33, 610\u2013616 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR72","doi-asserted-by":"crossref","first-page":"1260146","DOI":"10.3389\/fimmu.2023.1260146","volume":"14","author":"B Salaun","year":"2023","unstructured":"Salaun, B. et al. T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults. Front. Immunol. 14, 1260146 (2023).","journal-title":"Front. Immunol."},{"key":"1453_CR73","doi-asserted-by":"crossref","first-page":"e110741","DOI":"10.1371\/journal.pone.0110741","volume":"9","author":"MA Neller","year":"2014","unstructured":"Neller, M. A. et al. High efficiency ex vivo cloning of antigen-specific human effector T cells. PLoS ONE 9, e110741 (2014).","journal-title":"PLoS ONE"},{"key":"1453_CR74","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1073\/pnas.92.6.1921","volume":"92","author":"R Manz","year":"1995","unstructured":"Manz, R., Assenmacher, M., Pfl\u00fcger, E., Miltenyi, S. & Radbruch, A. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc. Natl Acad. Sci. USA 92, 1921\u20131925 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1453_CR75","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3389\/fimmu.2018.02462","volume":"9","author":"A Saxena","year":"2018","unstructured":"Saxena, A., Dagur, P. K., Desai, A. & McCoy, J. P. Jr. Ultrasensitive quantification of cytokine proteins in single lymphocytes from human blood following ex-vivo stimulation. Front. Immunol. 9, 2462 (2018).","journal-title":"Front. Immunol."},{"key":"1453_CR76","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.4049\/jimmunol.166.12.7634","volume":"166","author":"MJ Pittet","year":"2001","unstructured":"Pittet, M. J. et al. Ex vivo IFN\u03b3 secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J. Immunol. 166, 7634\u20137640 (2001).","journal-title":"J. Immunol."},{"key":"1453_CR77","doi-asserted-by":"crossref","first-page":"112998","DOI":"10.1016\/j.jim.2021.112998","volume":"492","author":"S Anvari","year":"2021","unstructured":"Anvari, S., Schuster, K., Grimbergen, A., Davis, C. M. & Makedonas, G. Attenuation of GARP expression on regulatory T cells by protein transport inhibitors. J. Immunol. Methods 492, 112998 (2021).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-1759(99)00010-1","volume":"224","author":"S Nylander","year":"1999","unstructured":"Nylander, S. & Kalies, I. Brefeldin A, but not monensin, completely blocks CD69 expression on mouse lymphocytes: efficacy of inhibitors of protein secretion in protocols for intracellular cytokine staining by flow cytometry. J. Immunol. Methods 224, 69\u201376 (1999).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR79","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature22976","volume":"547","author":"J Glanville","year":"2017","unstructured":"Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94\u201398 (2017).","journal-title":"Nature"},{"key":"1453_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-99","volume":"9","author":"V Sargentini","year":"2009","unstructured":"Sargentini, V. et al. Cytometric detection of antigen-specific IFN-\u03b3\/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect. Dis. 9, 99 (2009).","journal-title":"BMC Infect. Dis."},{"key":"1453_CR81","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/ijc.25955","volume":"129","author":"K Kakimi","year":"2011","unstructured":"Kakimi, K. et al. A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. Int. J. Cancer 129, 2836\u20132846 (2011).","journal-title":"Int. J. Cancer"},{"key":"1453_CR82","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/vaccines6030050","volume":"6","author":"G Bowyer","year":"2018","unstructured":"Bowyer, G. et al. Activation-induced markers detect vaccine-specific CD4+ T cell responses not measured by assays conventionally used in clinical trials. Vaccines 6, 50 (2018).","journal-title":"Vaccines"},{"key":"1453_CR83","doi-asserted-by":"crossref","first-page":"e0186998","DOI":"10.1371\/journal.pone.0186998","volume":"12","author":"S Reiss","year":"2017","unstructured":"Reiss, S. et al. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells. PLoS ONE 12, e0186998 (2017).","journal-title":"PLoS ONE"},{"key":"1453_CR84","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.4049\/jimmunol.0803548","volume":"183","author":"JJ Zaunders","year":"2009","unstructured":"Zaunders, J. J. et al. High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J. Immunol. 183, 2827\u20132836 (2009).","journal-title":"J. Immunol."},{"key":"1453_CR85","doi-asserted-by":"crossref","first-page":"626308","DOI":"10.3389\/fimmu.2021.626308","volume":"12","author":"A Sch\u00f6llhorn","year":"2021","unstructured":"Sch\u00f6llhorn, A. et al. Integrin activation enables sensitive detection of functional CD4+ and CD8+ T cells: application to characterize SARS-CoV-2 immunity. Front. Immunol. 12, 626308 (2021).","journal-title":"Front. Immunol."},{"key":"1453_CR86","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","volume":"413","author":"M Shipkova","year":"2012","unstructured":"Shipkova, M. & Wieland, E. Surface markers of lymphocyte activation and markers of cell proliferation. Clin. Chim. Acta 413, 1338\u20131349 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"1453_CR87","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4049\/jimmunol.1600318","volume":"197","author":"JM Dan","year":"2016","unstructured":"Dan, J. M. et al. A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4+ T cells in blood. J. Immunol. 197, 983\u2013993 (2016).","journal-title":"J. Immunol."},{"key":"1453_CR88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","volume":"281","author":"MR Betts","year":"2003","unstructured":"Betts, M. R. et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281, 65\u201378 (2003).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR89","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.167.3.1313","volume":"167","author":"JL Cannons","year":"2001","unstructured":"Cannons, J. L. et al. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167, 1313\u20131324 (2001).","journal-title":"J. Immunol."},{"key":"1453_CR90","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1084\/jem.168.5.1621","volume":"168","author":"M Cebri\u00e1n","year":"1988","unstructured":"Cebri\u00e1n, M. et al. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168, 1621\u20131637 (1988).","journal-title":"J. Exp. Med."},{"key":"1453_CR91","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/imcb.12636","volume":"101","author":"C Poloni","year":"2023","unstructured":"Poloni, C. et al. T-cell activation-induced marker assays in health and disease. Immunol. Cell Biol. 101, 491\u2013503 (2023).","journal-title":"Immunol. Cell Biol."},{"key":"1453_CR92","volume":"6","author":"T Halvorson","year":"2026","unstructured":"Halvorson, T. et al. Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows. Cell Rep. Methods 6, 101458 (2026).","journal-title":"Cell Rep. Methods"},{"key":"1453_CR93","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/jiu461","volume":"211","author":"WW Tong","year":"2015","unstructured":"Tong, W. W. et al. Human papillomavirus 16-specific T-cell responses and spontaneous regression of anal high-grade squamous intraepithelial lesions. J. Infect. Dis. 211, 405\u2013415 (2015).","journal-title":"J. Infect. Dis."},{"key":"1453_CR94","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jaci.2017.02.015","volume":"140","author":"L Cook","year":"2017","unstructured":"Cook, L. et al. Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease. J. Allergy Clin. Immunol. 140, 1592\u20131603.e8 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1453_CR95","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/eji.201344102","volume":"44","author":"N Seddiki","year":"2014","unstructured":"Seddiki, N. et al. Human antigen-specific CD4+ CD25+ CD134+ CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses. Eur. J. Immunol. 44, 1644\u20131661 (2014).","journal-title":"Eur. J. Immunol."},{"key":"1453_CR96","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.4049\/jimmunol.1202221","volume":"190","author":"P Bacher","year":"2013","unstructured":"Bacher, P. et al. Antigen-reactive T cell enrichment for direct, high-resolution analysis of the human naive and memory Th cell repertoire. J. Immunol. 190, 3967\u20133976 (2013).","journal-title":"J. Immunol."},{"key":"1453_CR97","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1053\/j.gastro.2020.11.043","volume":"160","author":"L Cook","year":"2021","unstructured":"Cook, L. et al. Recurrent Clostridioides difficile infection is associated with impaired T helper type 17 immunity to C difficile toxin B. Gastroenterology 160, 1410\u20131413.e4 (2021).","journal-title":"Gastroenterology"},{"key":"1453_CR98","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e15 (2020).","journal-title":"Cell"},{"key":"1453_CR99","doi-asserted-by":"crossref","first-page":"eabf4063","DOI":"10.1126\/science.abf4063","volume":"371","author":"JM Dan","year":"2021","unstructured":"Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371, eabf4063 (2021).","journal-title":"Science"},{"key":"1453_CR100","doi-asserted-by":"crossref","first-page":"100204","DOI":"10.1016\/j.xcrm.2021.100204","volume":"2","author":"A Tarke","year":"2021","unstructured":"Tarke, A. et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep. Med. 2, 100204 (2021).","journal-title":"Cell Rep. Med."},{"key":"1453_CR101","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","volume":"28","author":"JD Miller","year":"2008","unstructured":"Miller, J. D. et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28, 710\u2013722 (2008).","journal-title":"Immunity"},{"key":"1453_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-376","volume":"12","author":"R Schwenk","year":"2013","unstructured":"Schwenk, R. et al. Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1. Malar. J. 12, 376 (2013).","journal-title":"Malar. J."},{"key":"1453_CR103","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/2050640614540154","volume":"2","author":"A Christophersen","year":"2014","unstructured":"Christophersen, A. et al. Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. United European Gastroenterol. J. 2, 268\u2013278 (2014).","journal-title":"United European Gastroenterol. J."},{"key":"1453_CR104","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2012.10.021","volume":"38","author":"LF Su","year":"2013","unstructured":"Su, L. F., Kidd, B. A., Han, A., Kotzin, J. J. & Davis, M. M. Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults. Immunity 38, 373\u2013383 (2013).","journal-title":"Immunity"},{"key":"1453_CR105","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nprot.2012.037","volume":"7","author":"RS Andersen","year":"2012","unstructured":"Andersen, R. S. et al. Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers. Nat. Protoc. 7, 891\u2013902 (2012).","journal-title":"Nat. Protoc."},{"key":"1453_CR106","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","volume":"274","author":"JD Altman","year":"1996","unstructured":"Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94\u201396 (1996).","journal-title":"Science"},{"key":"1453_CR107","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1073\/pnas.89.8.3429","volume":"89","author":"DN Garboczi","year":"1992","unstructured":"Garboczi, D. N., Hung, D. T. & Wiley, D. C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl Acad. Sci. USA 89, 3429\u20133433 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1453_CR108","doi-asserted-by":"crossref","first-page":"eabg5669","DOI":"10.1126\/sciimmunol.abg5669","volume":"6","author":"V Mallajosyula","year":"2021","unstructured":"Mallajosyula, V. et al. CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients. Sci. Immunol. 6, eabg5669 (2021).","journal-title":"Sci. Immunol."},{"key":"1453_CR109","first-page":"E1890","volume":"113","author":"J Huang","year":"2016","unstructured":"Huang, J. et al. Detection, phenotyping, and quantification of antigen-specific T cells using a peptide-MHC dodecamer. Proc. Natl Acad. Sci. USA 113, E1890\u2013E1897 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1453_CR110","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nm0602-631","volume":"8","author":"M Knabel","year":"2002","unstructured":"Knabel, M. et al. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat. Med. 8, 631\u2013637 (2002).","journal-title":"Nat. Med."},{"key":"1453_CR111","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nm1360","volume":"12","author":"M Toebes","year":"2006","unstructured":"Toebes, M. et al. Design and use of conditional MHC class I ligands. Nat. Med. 12, 246\u2013251 (2006).","journal-title":"Nat. Med."},{"key":"1453_CR112","doi-asserted-by":"crossref","first-page":"eaau9039","DOI":"10.1126\/sciimmunol.aau9039","volume":"4","author":"SK Saini","year":"2019","unstructured":"Saini, S. K. et al. Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells. Sci. Immunol. 4, eaau9039 (2019).","journal-title":"Sci. Immunol."},{"key":"1453_CR113","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/384134a0","volume":"384","author":"DN Garboczi","year":"1996","unstructured":"Garboczi, D. N. et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134\u2013141 (1996).","journal-title":"Nature"},{"key":"1453_CR114","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41591-020-01143-2","volume":"27","author":"I Schulien","year":"2021","unstructured":"Schulien, I. et al. Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells. Nat. Med. 27, 78\u201385 (2021).","journal-title":"Nat. Med."},{"key":"1453_CR115","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20180156","volume":"215","author":"JJ Luimstra","year":"2018","unstructured":"Luimstra, J. J. et al. A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells. J. Exp. Med. 215, 1493\u20131504 (2018).","journal-title":"J. Exp. Med."},{"key":"1453_CR116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.11.003","volume":"69","author":"MA Rahman","year":"2021","unstructured":"Rahman, M. A., Murata, K., Burt, B. D. & Hirano, N. Changing the landscape of tumor immunology: novel tools to examine T cell specificity. Curr. Opin. Immunol. 69, 1\u20139 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"1453_CR117","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nmeth.1345","volume":"6","author":"SR Hadrup","year":"2009","unstructured":"Hadrup, S. R. et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat. Methods 6, 520\u2013526 (2009).","journal-title":"Nat. Methods"},{"key":"1453_CR118","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nbt.2593","volume":"31","author":"EW Newell","year":"2013","unstructured":"Newell, E. W. et al. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat. Biotechnol. 31, 623\u2013629 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR119","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nbt.3662","volume":"34","author":"AK Bentzen","year":"2016","unstructured":"Bentzen, A. K. et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat. Biotechnol. 34, 1037\u20131045 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s40425-019-0695-9","volume":"7","author":"M Fehlings","year":"2019","unstructured":"Fehlings, M. et al. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment. J. Immunother. Cancer 7, 249 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1453_CR121","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jim.2017.09.010","volume":"453","author":"M Fehlings","year":"2018","unstructured":"Fehlings, M. et al. Multiplex peptide-MHC tetramer staining using mass cytometry for deep analysis of the influenza-specific T-cell response in mice. J. Immunol. Methods 453, 30\u201336 (2018).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR122","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2013.00218","volume":"4","author":"J Schmidt","year":"2013","unstructured":"Schmidt, J., Dojcinovic, D., Guillaume, P. & Luescher, I. Analysis, isolation, and activation of antigen-specific CD4+ and CD8+ T cells by soluble MHC-peptide complexes. Front. Immunol. 4, 218 (2013).","journal-title":"Front. Immunol."},{"key":"1453_CR123","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41587-021-00836-4","volume":"39","author":"K Sugata","year":"2021","unstructured":"Sugata, K. et al. Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells. Nat. Biotechnol. 39, 958\u2013967 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2008.09.014","volume":"340","author":"A Lissina","year":"2009","unstructured":"Lissina, A. et al. Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J. Immunol. Methods 340, 11\u201324 (2009).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR125","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3324\/haematol.2022.280685","volume":"108","author":"E Tassi","year":"2023","unstructured":"Tassi, E. et al. Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation. Haematologica 108, 1530\u20131543 (2023).","journal-title":"Haematologica"},{"key":"1453_CR126","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009564","volume":"12","author":"KJ Fuchs","year":"2024","unstructured":"Fuchs, K. J. et al. DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation. J. Immunother. Cancer 12, e009564 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"1453_CR127","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","volume":"183","author":"PA Ott","year":"2020","unstructured":"Ott, P. A. et al. A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer. Cell 183, 347\u2013362.e24 (2020).","journal-title":"Cell"},{"key":"1453_CR128","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V98.3.754","volume":"98","author":"LE Gamadia","year":"2001","unstructured":"Gamadia, L. E. et al. Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers. Blood 98, 754\u2013761 (2001).","journal-title":"Blood"},{"key":"1453_CR129","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145476","volume":"131","author":"H Kared","year":"2021","unstructured":"Kared, H. et al. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. J. Clin. Invest. 131, e145476 (2021).","journal-title":"J. Clin. Invest."},{"key":"1453_CR130","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575\u2013579 (2018).","journal-title":"Nature"},{"key":"1453_CR131","doi-asserted-by":"crossref","first-page":"101810","DOI":"10.1016\/j.smim.2023.101810","volume":"69","author":"NP Weng","year":"2023","unstructured":"Weng, N. P. Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions. Semin. Immunol. 69, 101810 (2023).","journal-title":"Semin. Immunol."},{"key":"1453_CR132","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-021-03363-z","volume":"592","author":"M Platten","year":"2021","unstructured":"Platten, M. et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature 592, 463\u2013468 (2021).","journal-title":"Nature"},{"key":"1453_CR133","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.4049\/jimmunol.152.10.5109","volume":"152","author":"J Gorski","year":"1994","unstructured":"Gorski, J. et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J. Immunol. 152, 5109\u20135119 (1994).","journal-title":"J. Immunol."},{"key":"1453_CR134","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1073\/pnas.90.9.4319","volume":"90","author":"C Pannetier","year":"1993","unstructured":"Pannetier, C. et al. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl Acad. Sci. USA 90, 4319\u20134323 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1453_CR135","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/icb.2016.16","volume":"94","author":"AA Eltahla","year":"2016","unstructured":"Eltahla, A. A. et al. Linking the T cell receptor to the single cell transcriptome in antigen-specific human T cells. Immunol. Cell Biol. 94, 604\u2013611 (2016).","journal-title":"Immunol. Cell Biol."},{"key":"1453_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0335-7","volume":"8","author":"D Redmond","year":"2016","unstructured":"Redmond, D., Poran, A. & Elemento, O. Single-cell TCRseq: paired recovery of entire T-cell alpha and beta chain transcripts in T-cell receptors from single-cell RNAseq. Genome Med. 8, 80 (2016).","journal-title":"Genome Med."},{"key":"1453_CR137","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","volume":"114","author":"HS Robins","year":"2009","unstructured":"Robins, H. S. et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114, 4099\u20134107 (2009).","journal-title":"Blood"},{"key":"1453_CR138","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-0716-2756-3_2","volume":"2584","author":"J Ulbrich","year":"2023","unstructured":"Ulbrich, J., Lopez-Salmeron, V. & Gerrard, I. BD Rhapsody Single-Cell Analysis System workflow: from sample to multimodal single-cell sequencing data. Methods Mol. Biol. 2584, 29\u201356 (2023).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR139","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1101\/gr.092924.109","volume":"19","author":"JD Freeman","year":"2009","unstructured":"Freeman, J. D., Warren, R. L., Webb, J. R., Nelson, B. H. & Holt, R. A. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res. 19, 1817\u20131824 (2009).","journal-title":"Genome Res."},{"key":"1453_CR140","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ng.3581","volume":"48","author":"B Li","year":"2016","unstructured":"Li, B. et al. Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat. Genet. 48, 725\u2013732 (2016).","journal-title":"Nat. Genet."},{"key":"1453_CR141","doi-asserted-by":"crossref","first-page":"bbad220","DOI":"10.1093\/bib\/bbad220","volume":"24","author":"K Peng","year":"2023","unstructured":"Peng, K. et al. Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing. Brief. Bioinform. 24, bbad220 (2023).","journal-title":"Brief. Bioinform."},{"key":"1453_CR142","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41587-020-0656-3","volume":"39","author":"P Barennes","year":"2021","unstructured":"Barennes, P. et al. Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases. Nat. Biotechnol. 39, 236\u2013245 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR143","doi-asserted-by":"crossref","first-page":"e0152464","DOI":"10.1371\/journal.pone.0152464","volume":"11","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Systematic comparative evaluation of methods for investigating the TCR\u03b2 repertoire. PLoS ONE 11, e0152464 (2016).","journal-title":"PLoS ONE"},{"key":"1453_CR144","doi-asserted-by":"crossref","first-page":"100459","DOI":"10.1016\/j.crmeth.2023.100459","volume":"3","author":"R Genolet","year":"2023","unstructured":"Genolet, R. et al. TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs. Cell Rep. Methods 3, 100459 (2023).","journal-title":"Cell Rep. Methods"},{"key":"1453_CR145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fimmu.2018.00033","volume":"9","author":"KY Ma","year":"2018","unstructured":"Ma, K. Y. et al. Immune repertoire sequencing using molecular identifiers enables accurate clonality discovery and clone size quantification. Front. Immunol. 9, 33 (2018).","journal-title":"Front. Immunol."},{"key":"1453_CR146","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nmeth.1778","volume":"9","author":"T Kivioja","year":"2011","unstructured":"Kivioja, T. et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat. Methods 9, 72\u201374 (2011).","journal-title":"Nat. Methods"},{"key":"1453_CR147","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nmeth.2960","volume":"11","author":"M Shugay","year":"2014","unstructured":"Shugay, M. et al. Towards error-free profiling of immune repertoires. Nat. Methods 11, 653\u2013655 (2014).","journal-title":"Nat. Methods"},{"key":"1453_CR148","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3389\/fimmu.2017.01267","volume":"8","author":"T Oakes","year":"2017","unstructured":"Oakes, T. et al. Quantitative characterization of the T cell receptor repertoire of naive and memory subsets using an integrated experimental and computational pipeline which is robust, economical, and versatile. Front. Immunol. 8, 1267 (2017).","journal-title":"Front. Immunol."},{"key":"1453_CR149","doi-asserted-by":"crossref","first-page":"18220","DOI":"10.1074\/jbc.RA119.010676","volume":"294","author":"MG Wulf","year":"2019","unstructured":"Wulf, M. G. et al. Non-templated addition and template switching by Moloney murine leukemia virus (MMLV)-based reverse transcriptases co-occur and compete with each other. J. Biol. Chem. 294, 18220\u201318231 (2019).","journal-title":"J. Biol. Chem."},{"key":"1453_CR150","doi-asserted-by":"crossref","first-page":"bbab566","DOI":"10.1093\/bib\/bbab566","volume":"23","author":"S Dahal-Koirala","year":"2022","unstructured":"Dahal-Koirala, S. et al. TCRpower: quantifying the detection power of T-cell receptor sequencing with a novel computational pipeline calibrated by spike-in sequences. Brief. Bioinform. 23, bbab566 (2022).","journal-title":"Brief. Bioinform."},{"key":"1453_CR151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006874","volume":"15","author":"T Dupic","year":"2019","unstructured":"Dupic, T., Marcou, Q., Walczak, A. M. & Mora, T. Genesis of the alphabeta T-cell receptor. PLoS Comput. Biol. 15, e1006874 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"1453_CR152","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1073\/pnas.1409155111","volume":"111","author":"Q Qi","year":"2014","unstructured":"Qi, Q. et al. Diversity and clonal selection in the human T-cell repertoire. Proc. Natl Acad. Sci. USA 111, 13139\u201313144 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1453_CR153","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.immuni.2020.11.016","volume":"53","author":"P Bacher","year":"2020","unstructured":"Bacher, P. et al. Low-avidity CD4+ T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19. Immunity 53, 1258\u20131271.e5 (2020).","journal-title":"Immunity"},{"key":"1453_CR154","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nm.4051","volume":"22","author":"A Gros","year":"2016","unstructured":"Gros, A. et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat. Med. 22, 433\u2013438 (2016).","journal-title":"Nat. Med."},{"key":"1453_CR155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5624","volume":"7","author":"B Howie","year":"2015","unstructured":"Howie, B. et al. High-throughput pairing of T cell receptor alpha and beta sequences. Sci. Transl. Med. 7, 301ra131 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1453_CR156","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41592-025-02907-9","volume":"23","author":"MV Pogorelyy","year":"2026","unstructured":"Pogorelyy, M. V. et al. TIRTL-seq: deep, quantitative and affordable paired TCR repertoire sequencing. Nat. Methods 23, 56\u201364 (2026).","journal-title":"Nat. Methods"},{"key":"1453_CR157","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12865-016-0177-5","volume":"17","author":"K Kitaura","year":"2016","unstructured":"Kitaura, K., Shini, T., Matsutani, T. & Suzuki, R. A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) \u03b1 and \u03b2 repertoires and identifying potential new invariant TCR alpha chains. BMC Immunol. 17, 38 (2016).","journal-title":"BMC Immunol."},{"key":"1453_CR158","doi-asserted-by":"crossref","first-page":"102972","DOI":"10.1016\/j.ebiom.2020.102972","volume":"59","author":"JM Montagne","year":"2020","unstructured":"Montagne, J. M. et al. Ultra-efficient sequencing of T Cell receptor repertoires reveals shared responses in muscle from patients with Myositis. EBioMedicine 59, 102972 (2020).","journal-title":"EBioMedicine"},{"key":"1453_CR159","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194\u20131202 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR160","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68605","volume":"10","author":"K Mayer-Blackwell","year":"2021","unstructured":"Mayer-Blackwell, K. et al. TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs. Elife 10, e68605 (2021).","journal-title":"Elife"},{"key":"1453_CR161","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/j.cell.2023.06.020","volume":"186","author":"G Dolton","year":"2023","unstructured":"Dolton, G. et al. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy. Cell 186, 3333\u20133349.e27 (2023).","journal-title":"Cell"},{"key":"1453_CR162","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/sj.leu.2404467","volume":"21","author":"JH van Krieken","year":"2007","unstructured":"van Krieken, J. H. et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21, 201\u2013206 (2007).","journal-title":"Leukemia"},{"key":"1453_CR163","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fimmu.2020.00591","volume":"11","author":"HY Chan","year":"2020","unstructured":"Chan, H. Y. et al. A T cell receptor sequencing-based assay identifies cross-reactive recall CD8+ T cell clonotypes against autologous HIV-1 epitope variants. Front. Immunol. 11, 591 (2020).","journal-title":"Front. Immunol."},{"key":"1453_CR164","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146922","volume":"131","author":"AG Dykema","year":"2021","unstructured":"Dykema, A. G. et al. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses. J. Clin. Invest. 131, e146922 (2021).","journal-title":"J. Clin. Invest."},{"key":"1453_CR165","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012216","volume":"13","author":"K Lindner","year":"2025","unstructured":"Lindner, K. et al. ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer. J. Immunother. Cancer 13, e012216 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"1453_CR166","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.copbio.2020.07.010","volume":"65","author":"J Chiffelle","year":"2020","unstructured":"Chiffelle, J. et al. T-cell repertoire analysis and metrics of diversity and clonality. Curr. Opin. Biotechnol. 65, 284\u2013295 (2020).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1453_CR167","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tibtech.2016.09.010","volume":"35","author":"S Friedensohn","year":"2017","unstructured":"Friedensohn, S., Khan, T. A. & Reddy, S. T. Advanced methodologies in high-throughput sequencing of immune repertoires. Trends Biotechnol. 35, 203\u2013214 (2017).","journal-title":"Trends Biotechnol."},{"key":"1453_CR168","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-023-00284-1","volume":"4","author":"V Mhanna","year":"2024","unstructured":"Mhanna, V. et al. Adaptive immune receptor repertoire analysis. Nat. Rev. Methods Primers 4, 6 (2024).","journal-title":"Nat. Rev. Methods Primers"},{"key":"1453_CR169","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nmeth.3800","volume":"13","author":"MJT Stubbington","year":"2016","unstructured":"Stubbington, M. J. T. et al. T cell fate and clonality inference from single-cell transcriptomes. Nat. Methods 13, 329\u2013332 (2016).","journal-title":"Nat. Methods"},{"key":"1453_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24730-4","volume":"12","author":"DS Fischer","year":"2021","unstructured":"Fischer, D. S. et al. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through \u2018reverse phenotyping\u2019. Nat. Commun. 12, 4515 (2021).","journal-title":"Nat. Commun."},{"key":"1453_CR171","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nbt.2938","volume":"32","author":"A Han","year":"2014","unstructured":"Han, A., Glanville, J., Hansmann, L. & Davis, M. M. Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat. Biotechnol. 32, 684\u2013692 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR172","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nbt.4282","volume":"36","author":"SQ Zhang","year":"2018","unstructured":"Zhang, S. Q. et al. High-throughput determination of the antigen specificities of T cell receptors in single cells. Nat. Biotechnol. 36, 1156\u20131159 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR173","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41591-019-0472-9","volume":"25","author":"AG Chapuis","year":"2019","unstructured":"Chapuis, A. G. et al. T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. Nat. Med. 25, 1064\u20131072 (2019).","journal-title":"Nat. Med."},{"key":"1453_CR174","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41591-022-02128-z","volume":"29","author":"DS Hong","year":"2023","unstructured":"Hong, D. S. et al. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial. Nat. Med. 29, 104\u2013114 (2023).","journal-title":"Nat. Med."},{"key":"1453_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56547-w","volume":"16","author":"YC Chih","year":"2025","unstructured":"Chih, Y. C. et al. Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen. Nat. Commun. 16, 1262 (2025).","journal-title":"Nat. Commun."},{"key":"1453_CR176","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","volume":"385","author":"P Nathan","year":"2021","unstructured":"Nathan, P. et al. Overall survival benefit with tebentafusp in metastatic uveal melanoma. N. Engl. J. Med. 385, 1196\u20131206 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1453_CR177","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imr.12654","volume":"283","author":"K Schober","year":"2018","unstructured":"Schober, K., Buchholz, V. R. & Busch, D. H. TCR repertoire evolution during maintenance of CMV-specific T-cell populations. Immunol. Rev. 283, 113\u2013128 (2018).","journal-title":"Immunol. Rev."},{"key":"1453_CR178","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cells9061367","volume":"9","author":"K Schober","year":"2020","unstructured":"Schober, K., Muller, T. R. & Busch, D. H. Orthotopic T-cell receptor replacement-an \u201cenabler\u201d for TCR-based therapies. Cells 9, 1367 (2020).","journal-title":"Cells"},{"key":"1453_CR179","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","volume":"40","author":"KI Hanada","year":"2022","unstructured":"Hanada, K. I. et al. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. Cancer Cell 40, 479\u2013493.e6 (2022).","journal-title":"Cancer Cell"},{"key":"1453_CR180","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","volume":"596","author":"G Oliveira","year":"2021","unstructured":"Oliveira, G. et al. Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma. Nature 596, 119\u2013125 (2021).","journal-title":"Nature"},{"key":"1453_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49806-9","volume":"15","author":"F Drost","year":"2024","unstructured":"Drost, F. et al. Multi-modal generative modeling for joint analysis of single-cell T cell receptor and gene expression data. Nat. Commun. 15, 5577 (2024).","journal-title":"Nat. Commun."},{"key":"1453_CR182","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41587-021-00989-2","volume":"40","author":"SA Schattgen","year":"2022","unstructured":"Schattgen, S. A. et al. Integrating T cell receptor sequences and transcriptional profiles by clonotype neighbor graph analysis (CoNGA). Nat. Biotechnol. 40, 54\u201363 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR183","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41592-020-01020-3","volume":"18","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z., Xiong, D., Wang, X., Liu, H. & Wang, T. Mapping the functional landscape of T cell receptor repertoires by single-T cell transcriptomics. Nat. Methods 18, 92\u201399 (2021).","journal-title":"Nat. Methods"},{"key":"1453_CR184","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41590-024-01888-9","volume":"25","author":"N Borcherding","year":"2024","unstructured":"Borcherding, N. et al. CD4+ T cells exhibit distinct transcriptional phenotypes in the lymph nodes and blood following mRNA vaccination in humans. Nat. Immunol. 25, 1731\u20131741 (2024).","journal-title":"Nat. Immunol."},{"key":"1453_CR185","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41587-024-02161-y","volume":"43","author":"CL Tan","year":"2024","unstructured":"Tan, C. L. et al. Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy. Nat. Biotechnol. 43, 134\u2013142 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002889","volume":"8","author":"PL Klarenbeek","year":"2012","unstructured":"Klarenbeek, P. L. et al. Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS Pathog. 8, e1002889 (2012).","journal-title":"PLoS Pathog."},{"key":"1453_CR187","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/JVI.02003-14","volume":"89","author":"EB Remmerswaal","year":"2015","unstructured":"Remmerswaal, E. B. et al. Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function. J. Virol. 89, 568\u2013580 (2015).","journal-title":"J. Virol."},{"key":"1453_CR188","doi-asserted-by":"crossref","first-page":"113250","DOI":"10.1016\/j.celrep.2023.113250","volume":"42","author":"F Schmidt","year":"2023","unstructured":"Schmidt, F. et al. In-depth analysis of human virus-specific CD8+ T cells delineates unique phenotypic signatures for T cell specificity prediction. Cell Rep. 42, 113250 (2023).","journal-title":"Cell Rep."},{"key":"1453_CR189","doi-asserted-by":"crossref","first-page":"101085","DOI":"10.1016\/j.crmeth.2025.101085","volume":"5","author":"I Gem\u00fcnd","year":"2025","unstructured":"Gem\u00fcnd, I. et al. Characterization of human CMV-specific CD8+ T cells using multi-layer single-cell omics. Cell Rep. Methods 5, 101085 (2025).","journal-title":"Cell Rep. Methods"},{"key":"1453_CR190","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-024-03334-7","volume":"31","author":"J Lopez","year":"2025","unstructured":"Lopez, J. et al. Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial. Nat. Med. 31, 152\u2013164 (2025).","journal-title":"Nat. Med."},{"key":"1453_CR191","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1016\/j.cell.2025.06.019","volume":"188","author":"E Blass","year":"2025","unstructured":"Blass, E. et al. A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma. Cell 188, 5125\u20135141.e27 (2025).","journal-title":"Cell"},{"key":"1453_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12464-3","volume":"10","author":"PA Szabo","year":"2019","unstructured":"Szabo, P. A. et al. Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat. Commun. 10, 4706 (2019).","journal-title":"Nat. Commun."},{"key":"1453_CR193","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000525572","volume":"15","author":"A Jansen","year":"2023","unstructured":"Jansen, A. et al. Ex vivo and in vitro monocyte responses do not reflect in vivo immune responses and tolerance. J. Innate Immun. 15, 174\u2013187 (2023).","journal-title":"J. Innate Immun."},{"key":"1453_CR194","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41590-019-0320-6","volume":"20","author":"M Koutsakos","year":"2019","unstructured":"Koutsakos, M. et al. Human CD8+ T cell cross-reactivity across influenza A, B and C viruses. Nat. Immunol. 20, 613\u2013625 (2019).","journal-title":"Nat. Immunol."},{"key":"1453_CR195","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1073\/pnas.1318731111","volume":"111","author":"A Okhrimenko","year":"2014","unstructured":"Okhrimenko, A. et al. Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory. Proc. Natl Acad. Sci. USA 111, 9229\u20139234 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1453_CR196","doi-asserted-by":"crossref","first-page":"110071","DOI":"10.1016\/j.celrep.2021.110071","volume":"37","author":"MML Poon","year":"2021","unstructured":"Poon, M. M. L. et al. Heterogeneity of human anti-viral immunity shaped by virus, tissue, age, and sex. Cell Rep. 37, 110071 (2021).","journal-title":"Cell Rep."},{"key":"1453_CR197","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.immuni.2024.10.003","volume":"57","author":"J Davis-Porada","year":"2024","unstructured":"Davis-Porada, J. et al. Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues. Immunity 57, 2895\u20132913.e8 (2024).","journal-title":"Immunity"},{"key":"1453_CR198","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymeth.2024.06.005","volume":"229","author":"AA Charania","year":"2024","unstructured":"Charania, A. A. et al. A comprehensive preanalytical protocol for fresh solid tumor biospecimens. Methods 229, 108\u2013114 (2024).","journal-title":"Methods"},{"key":"1453_CR199","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi9091","volume":"10","author":"T Boschert","year":"2024","unstructured":"Boschert, T. et al. H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient. Sci. Adv. 10, eadi9091 (2024).","journal-title":"Sci. Adv."},{"key":"1453_CR200","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3390\/ijms25052476","volume":"25","author":"TA de Silva","year":"2024","unstructured":"de Silva, T. A. et al. Immunological landscapes in lung transplantation: insights from T cell profiling in BAL and PBMC. Int. J. Mol. Sci. 25, 2476 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1453_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36310-9","volume":"14","author":"XZ Huang","year":"2023","unstructured":"Huang, X. Z. et al. Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis. Nat. Commun. 14, 822 (2023).","journal-title":"Nat. Commun."},{"key":"1453_CR202","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s40425-019-0708-8","volume":"7","author":"HS Park","year":"2019","unstructured":"Park, H. S. et al. Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer. J. Immunother. Cancer 7, 268 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1453_CR203","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s, F. et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391, 2128\u20132139 (2018).","journal-title":"Lancet"},{"key":"1453_CR204","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1158\/1078-0432.CCR-18-0309","volume":"24","author":"DB Johnson","year":"2018","unstructured":"Johnson, D. B. et al. Quantitative spatial profiling of PD-1\/PD-L1 interaction and HLA-DR\/IDO-1 predicts improved autcomes of Anti-PD-1 therapies in metastatic melanoma. Clin. Cancer Res. 24, 5250\u20135260 (2018).","journal-title":"Clin. Cancer Res."},{"key":"1453_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05032-8","volume":"9","author":"SN Gettinger","year":"2018","unstructured":"Gettinger, S. N. et al. A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers. Nat. Commun. 9, 3196 (2018).","journal-title":"Nat. Commun."},{"key":"1453_CR206","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000563","volume":"8","author":"Z Abdulrahman","year":"2020","unstructured":"Abdulrahman, Z. et al. Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination. J. Immunother. Cancer 8, e000563 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"1453_CR207","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","volume":"174","author":"L Keren","year":"2018","unstructured":"Keren, L. et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging. Cell 174, 1373\u20131387.e19 (2018).","journal-title":"Cell"},{"key":"1453_CR208","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","volume":"182","author":"CM Schurch","year":"2020","unstructured":"Schurch, C. M. et al. Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell 182, 1341\u20131359.e19 (2020).","journal-title":"Cell"},{"key":"1453_CR209","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clinbiochem.2014.01.002","volume":"47","author":"M Shabihkhani","year":"2014","unstructured":"Shabihkhani, M. et al. The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. Clin. Biochem. 47, 258\u2013266 (2014).","journal-title":"Clin. Biochem."},{"key":"1453_CR210","doi-asserted-by":"crossref","first-page":"673042","DOI":"10.3389\/fmolb.2021.673042","volume":"8","author":"A Boisson","year":"2021","unstructured":"Boisson, A. et al. Fluorescent multiplex immunohistochemistry coupled with other state-of-the-art techniques to systematically characterize the tumor immune microenvironment. Front. Mol. Biosci. 8, 673042 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"1453_CR211","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.celrep.2019.06.049","volume":"28","author":"FJ Hartmann","year":"2019","unstructured":"Hartmann, F. J. et al. Comprehensive immune monitoring of clinical trials to advance human immunotherapy. Cell Rep. 28, 819\u2013831.e4 (2019).","journal-title":"Cell Rep."},{"key":"1453_CR212","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax5851","volume":"5","author":"L Keren","year":"2019","unstructured":"Keren, L. et al. MIBI-TOF: a multiplexed imaging platform relates cellular phenotypes and tissue structure. Sci. Adv. 5, eaax5851 (2019).","journal-title":"Sci. Adv."},{"key":"1453_CR213","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s42003-024-06568-w","volume":"7","author":"J Kim","year":"2024","unstructured":"Kim, J. et al. Spatial profiling of non-small cell lung cancer provides insights into tumorigenesis and immunotherapy response. Commun. Biol. 7, 930 (2024).","journal-title":"Commun. Biol."},{"key":"1453_CR214","doi-asserted-by":"crossref","first-page":"114392","DOI":"10.1016\/j.celrep.2024.114392","volume":"43","author":"C Quek","year":"2024","unstructured":"Quek, C. et al. Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy. Cell Rep. 43, 114392 (2024).","journal-title":"Cell Rep."},{"key":"1453_CR215","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00262-007-0304-5","volume":"56","author":"IJ De Vries","year":"2007","unstructured":"De Vries, I. J. et al. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. Cancer Immunol. Immunother. 56, 1667\u20131676 (2007).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR216","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.imbio.2011.01.003","volume":"216","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. Use of HLA-DR*08032\/E7 and HLA-DR*0818\/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors. Immunobiology 216, 947\u2013960 (2011).","journal-title":"Immunobiology"},{"key":"1453_CR217","doi-asserted-by":"crossref","first-page":"328","DOI":"10.14348\/molcells.2021.0052","volume":"44","author":"J Chang","year":"2021","unstructured":"Chang, J. MHC multimer: a molecular toolbox for immunologists. Mol. Cells 44, 328\u2013334 (2021).","journal-title":"Mol. Cells"},{"key":"1453_CR218","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj3671","volume":"8","author":"P Bonaventura","year":"2022","unstructured":"Bonaventura, P. et al. Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy. Sci. Adv. 8, eabj3671 (2022).","journal-title":"Sci. Adv."},{"key":"1453_CR219","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1240859","volume":"5","author":"I Poschke","year":"2016","unstructured":"Poschke, I. et al. Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma. Oncoimmunology 5, e1240859 (2016).","journal-title":"Oncoimmunology"},{"key":"1453_CR220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh9562","volume":"15","author":"Z Meng","year":"2023","unstructured":"Meng, Z. et al. Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer. Sci. Transl. Med. 15, eadh9562 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1453_CR221","doi-asserted-by":"crossref","first-page":"100620","DOI":"10.1016\/j.xcrm.2022.100620","volume":"3","author":"LJ Sudmeier","year":"2022","unstructured":"Sudmeier, L. J. et al. Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases. Cell Rep. Med. 3, 100620 (2022).","journal-title":"Cell Rep. Med."},{"key":"1453_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43201-6","volume":"14","author":"JK Benotmane","year":"2023","unstructured":"Benotmane, J. K. et al. High-sensitive spatially resolved T cell receptor sequencing with SPTCR-seq. Nat. Commun. 14, 7432 (2023).","journal-title":"Nat. Commun."},{"key":"1453_CR223","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 (2015).","journal-title":"Nat. Methods"},{"key":"1453_CR224","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.immuni.2022.09.002","volume":"55","author":"S Liu","year":"2022","unstructured":"Liu, S. et al. Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response. Immunity 55, 1940\u20131952.e5 (2022).","journal-title":"Immunity"},{"key":"1453_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11049-4","volume":"10","author":"M Singh","year":"2019","unstructured":"Singh, M. et al. High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes. Nat. Commun. 10, 3120 (2019).","journal-title":"Nat. Commun."},{"key":"1453_CR226","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf8486","volume":"382","author":"C Engblom","year":"2023","unstructured":"Engblom, C. et al. Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics. Science 382, eadf8486 (2023).","journal-title":"Science"},{"key":"1453_CR227","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/s41590-019-0544-5","volume":"20","author":"AA Tu","year":"2019","unstructured":"Tu, A. A. et al. TCR sequencing paired with massively parallel 3\u2032 RNA-seq reveals clonotypic T cell signatures. Nat. Immunol. 20, 1692\u20131699 (2019).","journal-title":"Nat. Immunol."},{"key":"1453_CR228","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cyto.a.23690","volume":"95","author":"A Reichard","year":"2019","unstructured":"Reichard, A. & Asosingh, K. Best practices for preparing a single cell suspension from solid tissues for flow cytometry. Cytometry A 95, 219\u2013226 (2019).","journal-title":"Cytometry A"},{"key":"1453_CR229","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/path.4284","volume":"231","author":"M Gerlinger","year":"2013","unstructured":"Gerlinger, M. et al. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. J. Pathol. 231, 424\u2013432 (2013).","journal-title":"J. Pathol."},{"key":"1453_CR230","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s43018-023-00548-5","volume":"4","author":"AI Kraemer","year":"2023","unstructured":"Kraemer, A. I. et al. The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer. Nat. Cancer 4, 608\u2013628 (2023).","journal-title":"Nat. Cancer"},{"key":"1453_CR231","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/1078-0432.CCR-19-3845","volume":"26","author":"IC Poschke","year":"2020","unstructured":"Poschke, I. C. et al. The outcome of ex vivo TIL expansion is highly influenced by spatial heterogeneity of the tumor T-cell repertoire and differences in intrinsic in vitro growth capacity between T-cell clones. Clin. Cancer Res. 26, 4289\u20134301 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1453_CR232","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.cell.2022.01.027","volume":"185","author":"K Lederer","year":"2022","unstructured":"Lederer, K. et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell 185, 1008\u20131024.e15 (2022).","journal-title":"Cell"},{"key":"1453_CR233","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2021.12.026","volume":"185","author":"PA Mudd","year":"2022","unstructured":"Mudd, P. A. et al. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell 185, 603\u2013613.e15 (2022).","journal-title":"Cell"},{"key":"1453_CR234","doi-asserted-by":"crossref","first-page":"104743","DOI":"10.1016\/j.ebiom.2023.104743","volume":"95","author":"L Ziegler","year":"2023","unstructured":"Ziegler, L. et al. Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination. EBioMedicine 95, 104743 (2023).","journal-title":"EBioMedicine"},{"key":"1453_CR235","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.cell.2025.04.005","volume":"188","author":"R Dhenni","year":"2025","unstructured":"Dhenni, R. et al. Macrophages direct location-dependent recall of B cell memory to vaccination. Cell 188, 3477\u20133496.e22 (2025).","journal-title":"Cell"},{"key":"1453_CR236","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijc.26355","volume":"131","author":"JD Boniface","year":"2012","unstructured":"Boniface, J. D., Poschke, I., Mao, Y. & Kiessling, R. Tumor-dependent down-regulation of the zeta-chain in T-cells is detectable in early breast cancer and correlates with immune cell function. Int. J. Cancer 131, 129\u2013139 (2012).","journal-title":"Int. J. Cancer"},{"key":"1453_CR237","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4161\/onci.21678","volume":"1","author":"J de Boniface","year":"2012","unstructured":"de Boniface, J., Mao, Y., Schmidt-Mende, J., Kiessling, R. & Poschke, I. Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients. Oncoimmunology 1, 1305\u20131312 (2012).","journal-title":"Oncoimmunology"},{"key":"1453_CR238","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg7836","volume":"6","author":"KA Connolly","year":"2021","unstructured":"Connolly, K. A. et al. A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836 (2021).","journal-title":"Sci. Immunol."},{"key":"1453_CR239","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00262-016-1892-8","volume":"65","author":"MI van Poelgeest","year":"2016","unstructured":"van Poelgeest, M. I. et al. Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer. Cancer Immunol. Immunother. 65, 1451\u20131463 (2016).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR240","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9440(10)64152-1","volume":"161","author":"RJ Vuylsteke","year":"2002","unstructured":"Vuylsteke, R. J. et al. Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells. Am. J. Pathol. 161, 19\u201326 (2002).","journal-title":"Am. J. Pathol."},{"key":"1453_CR241","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-0716-3690-9_3","volume":"2768","author":"K Schnatbaum","year":"2024","unstructured":"Schnatbaum, K. et al. An overview of peptides and peptide pools for antigen-specific stimulation in T-cell assays. Methods Mol. Biol. 2768, 29\u201350 (2024).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR242","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/358764a0","volume":"358","author":"RM Chicz","year":"1992","unstructured":"Chicz, R. M. et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764\u2013768 (1992).","journal-title":"Nature"},{"key":"1453_CR243","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.8023162","volume":"265","author":"M Bouvier","year":"1994","unstructured":"Bouvier, M. & Wiley, D. C. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265, 398\u2013402 (1994).","journal-title":"Science"},{"key":"1453_CR244","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-1759(01)00416-1","volume":"255","author":"HT Maecker","year":"2001","unstructured":"Maecker, H. T. et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255, 27\u201340 (2001).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.humimm.2004.02.017","volume":"65","author":"F Kiecker","year":"2004","unstructured":"Kiecker, F. et al. Analysis of antigen-specific T-cell responses with synthetic peptides\u2014what kind of peptide for which purpose? Hum. Immunol. 65, 523\u2013536 (2004).","journal-title":"Hum. Immunol."},{"key":"1453_CR246","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<538::AID-IJC11>3.0.CO;2-2","volume":"77","author":"P Chaux","year":"1998","unstructured":"Chaux, P., Vantomme, V., Coulie, P., Boon, T. & van der Bruggen, P. Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer. Int. J. Cancer 77, 538\u2013542 (1998).","journal-title":"Int. J. Cancer"},{"key":"1453_CR247","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1097-0045(20000501)43:2<88::AID-PROS3>3.0.CO;2-G","volume":"43","author":"N Meidenbauer","year":"2000","unstructured":"Meidenbauer, N., Harris, D. T., Spitler, L. E. & Whiteside, T. L. Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer. Prostate 43, 88\u2013100 (2000).","journal-title":"Prostate"},{"key":"1453_CR248","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00262-014-1593-0","volume":"63","author":"L Chudley","year":"2014","unstructured":"Chudley, L. et al. Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining. Cancer Immunol. Immunother. 63, 1199\u20131211 (2014).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR249","doi-asserted-by":"crossref","first-page":"982887","DOI":"10.3389\/fimmu.2022.982887","volume":"13","author":"S Begue","year":"2022","unstructured":"Begue, S. et al. Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium. Front. Immunol. 13, 982887 (2022).","journal-title":"Front. Immunol."},{"key":"1453_CR250","doi-asserted-by":"crossref","first-page":"1462688","DOI":"10.3389\/ftox.2024.1462688","volume":"6","author":"S Cochrane","year":"2024","unstructured":"Cochrane, S., Saib, O. & Sheffield, D. Use of serum-free media for peripheral blood mononuclear cell culture and the impact on T and B cell readouts. Front. Toxicol. 6, 1462688 (2024).","journal-title":"Front. Toxicol."},{"key":"1453_CR251","doi-asserted-by":"crossref","first-page":"S623","DOI":"10.1016\/j.annonc.2025.08.1590","volume":"36","author":"RJ Sullivan","year":"2025","unstructured":"Sullivan, R. J. et al. 954P A randomized phase II study of autogene cevumeran plus pembrolizumab (pembro) versus pembro in 1L advanced melanoma (IMcode001). Ann. Oncol. 36, S623\u2013S624 (2025).","journal-title":"Ann. Oncol."},{"key":"1453_CR252","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jim.2010.05.005","volume":"359","author":"G Afonso","year":"2010","unstructured":"Afonso, G. et al. Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms. J. Immunol. Methods 359, 28\u201336 (2010).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR253","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2007.02.003","volume":"322","author":"M Bull","year":"2007","unstructured":"Bull, M. et al. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 322, 57\u201369 (2007).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR254","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/aid.2006.0129","volume":"23","author":"LS Kierstead","year":"2007","unstructured":"Kierstead, L. S. et al. Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC. AIDS Res. Hum. Retroviruses 23, 86\u201392 (2007).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"1453_CR255","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/CVI.00435-06","volume":"14","author":"JG Smith","year":"2007","unstructured":"Smith, J. G. et al. Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clin. Vaccine Immunol. 14, 527\u2013537 (2007).","journal-title":"Clin. Vaccine Immunol."},{"key":"1453_CR256","doi-asserted-by":"crossref","first-page":"622","DOI":"10.4049\/immunohorizons.2300095","volume":"8","author":"S Ivison","year":"2024","unstructured":"Ivison, S. et al. Improving reliability of immunological assays by defining minimal criteria for cell fitness. Immunohorizons 8, 622\u2013634 (2024).","journal-title":"Immunohorizons"},{"key":"1453_CR257","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1208\/s12248-023-00861-y","volume":"25","author":"X Li","year":"2023","unstructured":"Li, X. et al. Optimization of peripheral blood mononuclear cell processing for improved clinical ELISpot assay performance. AAPS J. 25, 93 (2023).","journal-title":"AAPS J."},{"key":"1453_CR258","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40139-019-00192-8","volume":"7","author":"F Betsou","year":"2019","unstructured":"Betsou, F., Gaignaux, A., Ammerlaan, W., Norris, P. J. & Stone, M. Biospecimen science of blood for peripheral blood mononuclear cell (PBMC) functional applications. Curr. Pathobiol. Rep. 7, 17\u201327 (2019).","journal-title":"Curr. Pathobiol. Rep."},{"key":"1453_CR259","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12865-020-00345-0","volume":"21","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. Functional comparison of PBMCs isolated by Cell Preparation Tubes (CPT) vs. Lymphoprep Tubes. BMC Immunol. 21, 15 (2020).","journal-title":"BMC Immunol."},{"key":"1453_CR260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2249.2010.04272.x","volume":"163","author":"R Mallone","year":"2011","unstructured":"Mallone, R. et al. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin. Exp. Immunol. 163, 33\u201349 (2011).","journal-title":"Clin. Exp. Immunol."},{"key":"1453_CR261","doi-asserted-by":"crossref","first-page":"1382192","DOI":"10.3389\/fimmu.2024.1382192","volume":"15","author":"DJ Browne","year":"2024","unstructured":"Browne, D. J., Miller, C. M. & Doolan, D. L. Technical pitfalls when collecting, cryopreserving, thawing, and stimulating human T-cells. Front. Immunol. 15, 1382192 (2024).","journal-title":"Front. Immunol."},{"key":"1453_CR262","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1158\/1078-0432.CCR-20-3241","volume":"27","author":"HX Chen","year":"2021","unstructured":"Chen, H. X. et al. Network for biomarker immunoprofiling for cancer immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC). Clin. Cancer Res. 27, 5038\u20135048 (2021).","journal-title":"Clin. Cancer Res."},{"key":"1453_CR263","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002785","volume":"3","author":"SH van der Burg","year":"2011","unstructured":"van der Burg, S. H. et al. Harmonization of immune biomarker assays for clinical studies. Sci. Transl. Med. 3, 108ps144 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1453_CR264","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4161\/onci.22308","volume":"1","author":"A Hoos","year":"2012","unstructured":"Hoos, A., Janetzki, S. & Britten, C. M. Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring. Oncoimmunology 1, 1457\u20131459 (2012).","journal-title":"Oncoimmunology"},{"key":"1453_CR265","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2009.09.007","volume":"31","author":"S Janetzki","year":"2009","unstructured":"Janetzki, S. et al. \u201cMIATA\u201d\u2014Minimal Information about T Cell Assays. Immunity 31, 527\u2013528 (2009).","journal-title":"Immunity"},{"key":"1453_CR266","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cyto.a.20623","volume":"73","author":"JA Lee","year":"2008","unstructured":"Lee, J. A. et al. MIFlowCyt: the minimum information about a flow cytometry experiment. Cytometry A 73, 926\u2013930 (2008).","journal-title":"Cytometry A"},{"key":"1453_CR267","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41577-025-01238-2","volume":"26","author":"D Masopust","year":"2025","unstructured":"Masopust, D. et al. Guidelines for T cell nomenclature. Nat. Rev. Immunol. 26, 298\u2013313 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"1453_CR268","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00262-009-0681-z","volume":"58","author":"CM Britten","year":"2009","unstructured":"Britten, C. M. et al. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunol. Immunother. 58, 1701\u20131713 (2009).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR269","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00262-012-1359-5","volume":"62","author":"H Filbert","year":"2013","unstructured":"Filbert, H. et al. Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols. Cancer Immunol. Immunother. 62, 615\u2013627 (2013).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR270","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121867","volume":"3","author":"S Ivison","year":"2018","unstructured":"Ivison, S. et al. A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies. JCI Insight 3, e121867 (2018).","journal-title":"JCI Insight"},{"key":"1453_CR271","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00262-007-0378-0","volume":"57","author":"CM Britten","year":"2008","unstructured":"Britten, C. M. et al. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol. Immunother. 57, 289\u2013302 (2008).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR272","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cyto.a.24244","volume":"99","author":"LS Price","year":"2021","unstructured":"Price, L. S. et al. Gating harmonization guidelines for intracellular cytokine staining validated in Second International Multiconsortia Proficiency Panel conducted by Cancer Immunotherapy Consortium (CIC\/CRI). Cytometry A 99, 107\u2013116 (2021).","journal-title":"Cytometry A"},{"key":"1453_CR273","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00262-012-1282-9","volume":"61","author":"MJ Welters","year":"2012","unstructured":"Welters, M. J. et al. Harmonization of the intracellular cytokine staining assay. Cancer Immunol. Immunother. 61, 967\u2013978 (2012).","journal-title":"Cancer Immunol. Immunother."},{"key":"1453_CR274","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.2200934","volume":"210","author":"KS Fitzpatrick","year":"2023","unstructured":"Fitzpatrick, K. S. et al. Validation of ligand tetramers for the detection of antigen-specific lymphocytes. J. Immunol. 210, 1156\u20131165 (2023).","journal-title":"J. Immunol."},{"key":"1453_CR275","first-page":"51","volume":"302","author":"S Janetzki","year":"2005","unstructured":"Janetzki, S., Cox, J. H., Oden, N. & Ferrari, G. Standardization and validation issues of the ELISPOT assay. Methods Mol. Biol. 302, 51\u201386 (2005).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR276","doi-asserted-by":"crossref","first-page":"984642","DOI":"10.3389\/fimmu.2022.984642","volume":"13","author":"G Waerlop","year":"2022","unstructured":"Waerlop, G. et al. Harmonization and qualification of an IFN-\u03b3 Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. Front. Immunol. 13, 984642 (2022).","journal-title":"Front. Immunol."},{"key":"1453_CR277","doi-asserted-by":"crossref","first-page":"909297","DOI":"10.3389\/fimmu.2022.909297","volume":"13","author":"MC Bernard","year":"2022","unstructured":"Bernard, M. C. et al. Validation of a harmonized enzyme-linked-lectin-assay (ELLA-NI) based neuraminidase inhibition assay standard operating procedure (SOP) for quantification of N1 influenza antibodies and the use of a calibrator to improve the reproducibility of the ELLA-NI with reverse genetics viral and recombinant neuraminidase antigens: a FLUCOP collaborative study. Front. Immunol. 13, 909297 (2022).","journal-title":"Front. Immunol."},{"key":"1453_CR278","doi-asserted-by":"crossref","first-page":"113584","DOI":"10.1016\/j.jim.2023.113584","volume":"523","author":"G Waerlop","year":"2023","unstructured":"Waerlop, G. et al. Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-\u03b3 Enzyme-Linked ImmunoSpot (ELISpot) protocols. J. Immunol. Methods 523, 113584 (2023).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR279","unstructured":"EMA. ICH Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis\u2014Questions and Answers https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-and-study-sample-analysis-frequently-asked-questions-faq_en.pdf (2023)."},{"key":"1453_CR280","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4155\/bio-2023-0151","volume":"15","author":"G Sumner","year":"2023","unstructured":"Sumner, G. et al. 2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2 \u2013 Recommendations on Biomarkers\/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization. Bioanalysis 15, 861\u2013903 (2023).","journal-title":"Bioanalysis"},{"key":"1453_CR281","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/cyto.b.21397","volume":"94","author":"PA Chandran","year":"2018","unstructured":"Chandran, P. A. et al. Validation of immunomonitoring methods for application in clinical studies: the HLA-peptide multimer staining assay. Cytometry B Clin. Cytom. 94, 342\u2013353 (2018).","journal-title":"Cytometry B Clin. Cytom."},{"key":"1453_CR282","unstructured":"Clinical and Laboratory Standards Institute. H62 Validation of Assays Performed by Flow Cytometry. Edn 1 https:\/\/webstore.ansi.org\/standards\/clsi\/clsih62?ad_acct=0000&gad_source=1&gad_campaignid=22443797409&gbraid=0AAAAAD_gXFUWnF5o9zEOodCM6A9_w2B5k&gclid=EAIaIQobChMIzb7sycPVlgMVWWpHAR3rkQB_EAAYASAAEgJUIfD_BwE (2021)."},{"key":"1453_CR283","doi-asserted-by":"crossref","first-page":"20140291","DOI":"10.1098\/rstb.2014.0291","volume":"370","author":"DJ Laydon","year":"2015","unstructured":"Laydon, D. J., Bangham, C. R. & Asquith, B. Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370, 20140291 (2015).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"1453_CR284","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jim.2007.09.016","volume":"329","author":"V Venturi","year":"2008","unstructured":"Venturi, V. et al. Method for assessing the similarity between subsets of the T cell receptor repertoire. J. Immunol. Methods 329, 67\u201380 (2008).","journal-title":"J. Immunol. Methods"},{"key":"1453_CR285","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-0716-2712-9_16","volume":"2574","author":"K Mayer-Blackwell","year":"2022","unstructured":"Mayer-Blackwell, K., Fiore-Gartland, A. & Thomas, P. G. Flexible distance-based TCR analysis in Python with tcrdist3. Methods Mol. Biol. 2574, 309\u2013366 (2022).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR286","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-0716-2712-9_15","volume":"2574","author":"C Wang","year":"2022","unstructured":"Wang, C., Huang, H. & Davis, M. M. Grouping T-cell antigen receptors by specificity. Methods Mol. Biol. 2574, 291\u2013307 (2022).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR287","doi-asserted-by":"crossref","first-page":"D1057","DOI":"10.1093\/nar\/gkz874","volume":"48","author":"DV Bagaev","year":"2020","unstructured":"Bagaev, D. V. et al. VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium. Nucleic Acids Res. 48, D1057\u2013D1062 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1453_CR288","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36999-0","volume":"13","author":"K Hedman \u00c5","year":"2023","unstructured":"Hedman \u00c5, K. et al. Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs. Sci. Rep. 13, 10058 (2023).","journal-title":"Sci. Rep."},{"key":"1453_CR289","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2010.05881.x","volume":"1217","author":"DA Zlotoff","year":"2011","unstructured":"Zlotoff, D. A. & Bhandoola, A. Hematopoietic progenitor migration to the adult thymus. Ann. N. Y. Acad. Sci. 1217, 122\u2013138 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1453_CR290","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun, L., Su, Y., Jiao, A., Wang, X. & Zhang, B. T cells in health and disease. Signal Transduct. Target. Ther. 8, 235 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1453_CR291","doi-asserted-by":"crossref","first-page":"592569","DOI":"10.3389\/fimmu.2020.592569","volume":"11","author":"J Busselaar","year":"2020","unstructured":"Busselaar, J., Tian, S., van Eenennaam, H. & Borst, J. Helpless priming sends CD8+ T cells on the road to exhaustion. Front. Immunol. 11, 592569 (2020).","journal-title":"Front. Immunol."},{"key":"1453_CR292","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41577-024-01040-6","volume":"24","author":"N Lam","year":"2024","unstructured":"Lam, N., Lee, Y. & Farber, D. L. A guide to adaptive immune memory. Nat. Rev. Immunol. 24, 810\u2013829 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1453_CR293","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","volume":"55","author":"CH Koh","year":"2023","unstructured":"Koh, C. H., Lee, S., Kwak, M., Kim, B. S. & Chung, Y. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp. Mol. Med. 55, 2287\u20132299 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1453_CR294","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.166.3906.747","volume":"166","author":"HR Hulett","year":"1969","unstructured":"Hulett, H. R., Bonner, W. A., Barrett, J. & Herzenberg, L. A. Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence. Science 166, 747\u2013749 (1969).","journal-title":"Science"},{"key":"1453_CR295","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1073\/pnas.76.8.4061","volume":"76","author":"EL Reinherz","year":"1979","unstructured":"Reinherz, E. L., Kung, P. C., Goldstein, G. & Schlossman, S. F. Separation of functional subsets of human T cells by a monoclonal antibody. Proc. Natl Acad. Sci. USA 76, 4061\u20134065 (1979).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1453_CR296","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4939-7346-0_8","volume":"1678","author":"KM McKinnon","year":"2018","unstructured":"McKinnon, K. M. Multiparameter conventional flow cytometry. Methods Mol. Biol. 1678, 139\u2013150 (2018).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR297","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/eji.201343751","volume":"43","author":"YD Mahnke","year":"2013","unstructured":"Mahnke, Y. D., Brodie, T. M., Sallusto, F., Roederer, M. & Lugli, E. The who\u2019s who of T-cell differentiation: human memory T-cell subsets. Eur. J. Immunol. 43, 2797\u20132809 (2013).","journal-title":"Eur. J. Immunol."},{"key":"1453_CR298","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-0716-2811-9_6","volume":"2593","author":"HK Mishra","year":"2023","unstructured":"Mishra, H. K. Clinical applications of flow cytometry in cancer immunotherapies: from diagnosis to treatments. Methods Mol. Biol. 2593, 93\u2013112 (2023).","journal-title":"Methods Mol. Biol."},{"key":"1453_CR299","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nchembio.2007.59","volume":"4","author":"PO Krutzik","year":"2008","unstructured":"Krutzik, P. O., Crane, J. M., Clutter, M. R. & Nolan, G. P. High-content single-cell drug screening with phosphospecific flow cytometry. Nat. Chem. Biol. 4, 132\u2013142 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"1453_CR300","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth872","volume":"3","author":"PO Krutzik","year":"2006","unstructured":"Krutzik, P. O. & Nolan, G. P. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat. Methods 3, 361\u2013368 (2006).","journal-title":"Nat. Methods"},{"key":"1453_CR301","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/mps7020028","volume":"7","author":"S Dimitriadis","year":"2024","unstructured":"Dimitriadis, S. et al. Imaging flow cytometry: development, present applications, and future challenges. Methods Protoc. 7, 28 (2024).","journal-title":"Methods Protoc."},{"key":"1453_CR302","doi-asserted-by":"crossref","first-page":"1287884","DOI":"10.3389\/fmed.2023.1287884","volume":"10","author":"WG Telford","year":"2023","unstructured":"Telford, W. G. Flow cytometry and cell sorting. Front. Med. 10, 1287884 (2023).","journal-title":"Front. Med."},{"key":"1453_CR303","doi-asserted-by":"crossref","first-page":"815828","DOI":"10.3389\/fimmu.2022.815828","volume":"13","author":"A Iyer","year":"2022","unstructured":"Iyer, A., Hamers, A. A. J. & Pillai, A. B. CyTOF\u00ae for the masses. Front. Immunol. 13, 815828 (2022).","journal-title":"Front. Immunol."},{"key":"1453_CR304","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/s41590-024-01937-3","volume":"25","author":"J Garcia Castillo","year":"2024","unstructured":"Garcia Castillo, J. et al. A mass cytometry method pairing T cell receptor and differentiation state analysis. Nat. Immunol. 25, 1754\u20131763 (2024).","journal-title":"Nat. Immunol."},{"key":"1453_CR305","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.it.2012.02.010","volume":"33","author":"SC Bendall","year":"2012","unstructured":"Bendall, S. C., Nolan, G. P., Roederer, M. & Chattopadhyay, P. K. A deep profiler\u2019s guide to cytometry. Trends Immunol. 33, 323\u2013332 (2012).","journal-title":"Trends Immunol."},{"key":"1453_CR306","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.coi.2013.07.004","volume":"25","author":"ZB Bjornson","year":"2013","unstructured":"Bjornson, Z. B., Nolan, G. P. & Fantl, W. J. Single-cell mass cytometry for analysis of immune system functional states. Curr. Opin. Immunol. 25, 484\u2013494 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"1453_CR307","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41587-019-0033-2","volume":"37","author":"Z Good","year":"2019","unstructured":"Good, Z. et al. Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells. Nat. Biotechnol. 37, 259\u2013266 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR308","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41423-021-00783-9","volume":"19","author":"V Purohit","year":"2022","unstructured":"Purohit, V., Wagner, A., Yosef, N. & Kuchroo, V. K. Systems-based approaches to study immunometabolism. Cell. Mol. Immunol. 19, 409\u2013420 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"1453_CR309","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cll.2023.05.004","volume":"43","author":"A Koladiya","year":"2023","unstructured":"Koladiya, A. & Davis, K. L. Advances in clinical cass Cytometry. Clin. Lab. Med. 43, 507\u2013519 (2023).","journal-title":"Clin. Lab. Med."},{"key":"1453_CR310","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cyto.a.23053","volume":"91","author":"Q Chang","year":"2017","unstructured":"Chang, Q. et al. Imaging mass cytometry. Cytometry A 91, 160\u2013169 (2017).","journal-title":"Cytometry A"},{"key":"1453_CR311","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","volume":"11","author":"C Giesen","year":"2014","unstructured":"Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11, 417\u2013422 (2014).","journal-title":"Nat. Methods"},{"key":"1453_CR312","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/cyto.a.24841","volume":"105","author":"AJ Konecny","year":"2024","unstructured":"Konecny, A. J., Mage, P. L., Tyznik, A. J., Prlic, M. & Mair, F. OMIP-102: 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells. Cytometry A 105, 430\u2013436 (2024).","journal-title":"Cytometry A"},{"key":"1453_CR313","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cyto.a.24566","volume":"101","author":"JP Nolan","year":"2022","unstructured":"Nolan, J. P. The evolution of spectral flow cytometry. Cytometry A 101, 812\u2013817 (2022).","journal-title":"Cytometry A"},{"key":"1453_CR314","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2016.04.019","volume":"165","author":"MH Spitzer","year":"2016","unstructured":"Spitzer, M. H. & Nolan, G. P. Mass cytometry: single cells, many features. Cell 165, 780\u2013791 (2016).","journal-title":"Cell"},{"key":"1453_CR315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/ijlh.14098","volume":"45","author":"JR Brestoff","year":"2023","unstructured":"Brestoff, J. R. Full spectrum flow cytometry in the clinical laboratory. Int. J. Lab. Hematol. 45, 44\u201349 (2023).","journal-title":"Int. J. Lab. Hematol."},{"key":"1453_CR316","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/ni.3485","volume":"17","author":"EW Newell","year":"2016","unstructured":"Newell, E. W. & Cheng, Y. Mass cytometry: blessed with the curse of dimensionality. Nat. Immunol. 17, 890\u2013895 (2016).","journal-title":"Nat. Immunol."},{"key":"1453_CR317","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-biodatasci-020422-050255","volume":"6","author":"SM Guldberg","year":"2023","unstructured":"Guldberg, S. M., Okholm, T. L. H., McCarthy, E. E. & Spitzer, M. H. Computational methods for single-cell proteomics. Annu. Rev. Biomed. Data Sci. 6, 47\u201371 (2023).","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"1453_CR318","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nbt.2594","volume":"31","author":"AD Amir el","year":"2013","unstructured":"Amir el, A. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545\u2013552 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR319","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2018","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38\u201344 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR320","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nmeth.3863","volume":"13","author":"N Samusik","year":"2016","unstructured":"Samusik, N., Good, Z., Spitzer, M. H., Davis, K. L. & Nolan, G. P. Automated mapping of phenotype space with single-cell data. Nat. Methods 13, 493\u2013496 (2016).","journal-title":"Nat. Methods"},{"key":"1453_CR321","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cyto.a.23030","volume":"89","author":"LM Weber","year":"2016","unstructured":"Weber, L. M. & Robinson, M. D. Comparison of clustering methods for high-dimensional single-cell flow and mass cytometry data. Cytometry A 89, 1084\u20131096 (2016).","journal-title":"Cytometry A"},{"key":"1453_CR322","unstructured":"Dotamics. OMIQ https:\/\/www.omiq.ai\/ (2024)."},{"key":"1453_CR323","first-page":"S69","volume":"78","author":"Y Qian","year":"2010","unstructured":"Qian, Y. et al. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin. Cytom. 78, S69\u2013S82 (2010).","journal-title":"Cytometry B Clin. Cytom."},{"key":"1453_CR324","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nbt.1991","volume":"29","author":"P Qiu","year":"2011","unstructured":"Qiu, P. et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 29, 886\u2013891 (2011).","journal-title":"Nat. Biotechnol."},{"key":"1453_CR325","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.21015","volume":"79","author":"M Roederer","year":"2011","unstructured":"Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79, 167\u2013174 (2011).","journal-title":"Cytometry A"},{"key":"1453_CR326","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A 87, 636\u2013645 (2015).","journal-title":"Cytometry A"},{"key":"1453_CR327","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/bioinformatics\/btx054","volume":"33","author":"HC Lee","year":"2017","unstructured":"Lee, H. C., Kosoy, R., Becker, C. E., Dudley, J. T. & Kidd, B. A. Automated cell type discovery and classification through knowledge transfer. Bioinformatics 33, 1689\u20131695 (2017).","journal-title":"Bioinformatics"},{"key":"1453_CR328","doi-asserted-by":"crossref","first-page":"100619","DOI":"10.1016\/j.crmeth.2023.100619","volume":"3","author":"T Liechti","year":"2023","unstructured":"Liechti, T. et al. A robust pipeline for high-content, high-throughput immunophenotyping reveals age- and genetics-dependent changes in blood leukocytes. Cell Rep. Methods 3, 100619 (2023).","journal-title":"Cell Rep. Methods"},{"key":"1453_CR329","doi-asserted-by":"crossref","first-page":"2234792","DOI":"10.1080\/21645515.2023.2234792","volume":"19","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Li, J. & Lin, L. Statistical and machine learning methods for immunoprofiling based on single-cell data. Hum. Vaccin. Immunother. 19, 2234792 (2023).","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41596-026-01453-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-026-01453-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41596-026-01453-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:54:40Z","timestamp":1791298480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41596-026-01453-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":329,"alternative-id":["1453"],"URL":"https:\/\/doi.org\/10.1038\/s41596-026-01453-8","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.L. and V.D. are employed by CureVac SE. B.S. is employed by GSK and holds shares in GSK. K.F. is employed by CureVac Netherlands B.V. and holds shares in BioNTech. L. Bunse is a patent holder on \u2018Gene Signatures for the selection of tumor-reactive T cell receptor\u2019 (PCT\/EP2022\/057672). M.F. is an employee and shareholder of ImmunoScape Pte Ltd. L. Brix is employed by Immudex. S.D.K. is employed by CureVac SE and holds shares in BioNTech.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}